Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
22.93 USD | +0.58% | -.--% | +526.50% |
Jun. 13 | AbbVie inks immune disorder drug licensing deal with China's FutureGen | RE |
May. 24 | Landos Biopharma, Inc.(NasdaqCM:LABP) dropped from S&P TMI Index | CI |
- Stock Market
- Equities
- LABP Stock
- News Landos Biopharma, Inc.
- Press Releases